doi:10.1124/pharmrev.123.001045
Brand-name medications such as Wegovy (semaglutide), Ozempic (semaglutide), Zepbound (tirzepatide), and Mounjaro (tirzepatide) are FDA-approved for specific indications and are prescribed only when medically appropriate
GLP-1RAs have shown benefits in managing hypertension, diabetes, obesity, heart failure, atherosclerosis, and obstructive sleep apnea, which collectively lower AF risk [7]
Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: an eight RCTs meta-analysis
doi: 10.1186/1479-5868-9-78 Summary Keywords type 2 diabetes, exercise-as-a-medicine, training, metabolism, health Citation Codella R, Senesi P and Luzi L (2025) GLP-1 agonists and exercise: the future of lifestyle prioritization
You no longer need an obstructive sleep apnea diagnosis to qualify